Multimodality Imaging For Clinical Research: The Role Of Bio-photonics | 73394
OMICS Journal of Radiology
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
In order to see the bench-to-bedside dream of translational research become a reality, we need to develop imaging approaches
that is technologically sophisticated, allow deployment into a clinical setting. Multimodality imaging is gaining adoption, but
the bio-photonic component is absent or un-sophisticated. Our focus area is where light and patient meet, and improvements
that yield better outcomes, by identifying/addressing the obstacles preventing timely clinical adoption of laboratory-based
advances, not the least of which is the difficulty of detecting, characterizing and monitoring very small entities (molecules,
cells) within the human body, especially quantitatively, dynamically, and preferably without contrast agents. How and where
we look becomes critically important, especially if one targets (as one should) early diagnosis; for this, new tools and strategies
are needed, with likely new outcomes. We proposed and implemented an optical multimode approach to biomedical optical
imaging at all levels, featuring hyperspectral imaging, and optimized for earlier, more quantitative/reproducible detection of
abnormalities and a tighter spatio-temporal coupling between such diagnosis and intervention. Addressing major areas of
unmet need in the clinical realm with these new approaches should yield important improvements in disease management.
Our work on cancer, stem cells, vascular and neuro (specifically highlighting very early detection of Alzheimer’s disease)
applications will be described, with emphasis on the new technologies needed to achieve the desired imaging performance.
Thoughts about better ways for academia, the clinical and the corporate world to work together for innovative imaging solutions
and their use for addressing major disease will be briefly outlined.
Daniel L Farkas is a former Fulbright scholar, directed a National Science and Technology Center at Carnegie Mellon University. He was Professor of Bioengineering at University of Pittsburgh, and Vice-chairman for research and; Professor of Surgery at Cedars-Sinai Medical Center. He has 200+ publications, 11 editorial boards, $80 million funding, 32 international conferences chaired, and several prestigious awards. His focus is on translational biomedical optics, in academia and startups he founded.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals